| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| (+)-jq1 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of testis[MeSHID:D013736] |
NA | phase 1 | inhibitor |
| (+)-jq1 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of testis[MeSHID:D013736] |
NA | phase 1 | unknown |
| (+)-jq1 | bromodomain testis-specific protein | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of testis[MeSHID:D013736] |
NA | phase 1 | unknown |
| (+)-jq1 | bromodomain testis-specific protein | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of testis[MeSHID:D013736] |
NA | phase 1 | inhibitor |
| click here to return to the previous page | ||||||||